SCHEMBL7428686

SCHEMBL7428686

CCOC(=O)C(CC(C)C)NCC(C(=O)OCC)c1csc(-c2ccccc2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.56
MAPT P10636 3/20 0.43
RARA P10276 1/20 0.43
RARB P10826 1/20 0.43
RARG P13631 1/20 0.43
CDC7 O00311 2/20 0.41
DBF4 Q9UBU7 2/20 0.41
TRPM8 Q7Z2W7 2/20 0.41
SMN1; SMN2 Q16637 4/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 2/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7421947 0.96 CTSK (0.56) CTSKMAPTRARARARBRARG
SCHEMBL7417883 0.95 CTSK (0.55) CTSKMAPTRARARARBRARG
SCHEMBL4717602 0.88 CTSK (0.64) CTSKMAPTRARARARBRARG
SCHEMBL1655302 0.85 CTSK (0.62) CTSKMAPTSMN1; SMN2KDM4EHTT
SCHEMBL16746841 0.79 CTSK (0.51) CTSKMAPTRARARARBRARG
SCHEMBL7425252 0.78 CTSK (0.54) CTSKMAPTCDC7DBF4SMN1; SMN2
SCHEMBL4713366 0.77 CTSK (0.70) CTSKMAPTSMN1; SMN2KDM4EHTT
SCHEMBL5870222 0.77 MAPT (0.48) CTSKMAPTSMN1; SMN2KDM4ERAB9A
SCHEMBL7426736 0.75 CTSK (0.48) CTSKMAPTSMN1; SMN2KDM4EHTT
SCHEMBL5870340 0.75 MAPT (0.47) CTSKMAPTSMN1; SMN2KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002039997-A2 ACE-2 MODULATING COMPOUNDS AND USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-05-23 WO disclosed